INSURANCE/HEALTH: Requires health insurance coverage for histotripsy procedures (EN NO IMPACT See Note)

The creation of a new advisory board within the Department of Insurance to review and recommend rare cancer treatments was entirely removed.

The requirement for the advisory board to hold quarterly public meetings and submit formal reports to the legislature was deleted.

The bill's focus changed from 'rare cancers' generally to specifically covering histotripsy procedures for primary and metastatic liver tumors.

A specific definition for 'histotripsy' was added, describing it as a non-invasive procedure using high-intensity sound waves to destroy liver cancer tissue.

Coverage eligibility was narrowed from a broad category of rare cancers to specifically include primary and metastatic liver tumors.

Removed specific eligibility criteria for histotripsy coverage, including conditions like residual disease after chemotherapy and tumor size limits.

Removed the requirement for health insurers to cover histotripsy procedures and the definition of histotripsy.

Added the creation of an advisory board within the Department of Insurance to review and provide medical recommendations for new treatments of rare cancers.

Added a list of twelve specific members to the advisory board, including representatives from the Department of Health, Medicaid, the Surgeon General, and various cancer research institutions.

Added a requirement for the advisory board to hold quarterly public meetings and submit formal written reports to the legislature.

Added authority for the Insurance Commissioner to promulgate administrative rules to implement the new advisory board provisions.